Ion channel therapeutic monoclonal antibodies
Ion channel therapeutic monoclonal antibodies · 22. October 2022
SYnAbs' unique approach generating ultra-specific therapeutic monoclonals to ion channels and effectively treat channelopathies thanks to a unique antibody platform
Ion channel therapeutic monoclonal antibodies · 12. July 2022
SYnAbs has developed R&D and therapeutic monoclonal antibodies against transporters and ion channel such as glutamate EAAT transmembrane targets thanks to peptide and syngeneic cell immunization strategies
Ion channel therapeutic monoclonal antibodies · 25. January 2021
SYnAbs develops therapeutic effector monoclonal antibodies against ion channel transmembrane proteins thanks to DNA and cell immunization technologies
Ion channel therapeutic monoclonal antibodies · 11. January 2021
From Galvani' spark to the three-dimensional structure of ion channels, learn the fabulous history of unique transmembrane proteins
SYnAbs S.A.
Rue Auguste Piccard, 48
I-Tech Incubator 2
B-6041 Gosselies
Belgium
BE 0637.716.206
